HLI CELLULAR THERAPEUTICS LLC has a total of 21 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2004. It filed its patents most often in Australia, EPO (European Patent Office) and Singapore. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are TOP PHARM LAB, ELIASOF SCOTT and VIROCELL INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Singapore | 3 | |
#4 | Brazil | 2 | |
#5 | Canada | 1 | |
#6 | Hong Kong | 1 | |
#7 | Israel | 1 | |
#8 | Japan | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | United States | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Object sterilising | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Kaplunovsky Aleksandr | 8 |
#2 | Zaka Raihana | 8 |
#3 | Herzberg Uri | 7 |
#4 | Ye Qian | 7 |
#5 | Bhatia Mohit B | 6 |
#6 | Mohit B Bhatia | 4 |
#7 | Takebe Naoko | 4 |
#8 | Uri Herzberg | 4 |
#9 | Qian Ye | 3 |
#10 | Aleksandr Kaplunovsky | 3 |
Publication | Filing date | Title |
---|---|---|
AU2013203832A1 | Modified erythrocyte precursor cells and uses thereof | |
BRPI0711599A2 | methods for collecting and using placental umbilical cord blood stem cells |